Chronic viral infections – including HIV, hepatitis, and HSV – present complex clinical, treatment, and prevention challenges requiring deep real-world intelligence. As therapeutic advances expand treatment options and prevention strategies evolve, robust evidence capturing authentic patient experiences and clinical practice patterns is essential for informing treatment strategies, optimizing prevention approaches including pre-exposure prophylaxis (PrEP), supporting healthcare access decisions, and engaging clinician and patient communities.
Adelphi Real World’s Disease Specific Programmes (DSPs) in Infectious Diseases are designed to meet these evidence demands for chronic viral infections. Additionally, we have a secondary data team with expertise in infectious diseases.
Our Infectious Disease DSPs engage specialist clinicians and affected patients to generate actionable evidence grounded in real-world practice:
Disease Recognition & Clinical Management
Understand how specialists diagnose, stage, and manage HIV, hepatitis, and HSV – capturing diagnostic approaches, disease severity assessment, and treatment initiation decision-making in routine clinical settings.
Treatment Pathways & Therapeutic Strategies
Benchmark real-world therapy selection: how clinicians choose, initiate, and optimize antiretroviral treatments, hepatitis therapies, and antiviral agents – from first-line therapies through advanced options – including adherence and resistance management.
Prevention & Risk Mitigation
Explore prevention strategies and risk assessment approaches: how specialists implement and optimize preventive interventions, including reasons for PrEP uptake and reasons for not taking PrEP, and adherence to treatment and PrEP.
Clinical Outcomes & Disease Control
Understanding real-world effectiveness: viral suppression, disease stabilization, treatment success rates, undetectable equals untransmittable (U=U) outcomes, functional improvements, and quality of life across diverse patient populations and healthcare systems.
Patient Perspective & Lived Experience
Capture the patient voice: symptom severity and duration, treatment tolerability, side effect burden, impact on work and daily activities, healthcare access challenges, and psychosocial wellbeing.
Treatment Gaps & Emerging Needs
Capture the patient voice: treatment tolerability, side effect burden, adherence challenges, impact of stigma, quality of life, psychosocial wellbeing, and prevention acceptance across chronic viral infections.
Understanding physician needs across reasons for choice of treatment, side effects, perceptions of future treatment, and attitudes towards disease management
Chronic Viral Infection Disease Specific Programmes (DSP) Portfolio
Chronic Viral Infection Disease Specific Programmes (DSP) Portfolio
Why Partner With Adelphi?
Chronic Viral Infection Expertise
Deep specialization across HIV, hepatitis, and HSV management and prevention strategies.
Specialist Clinician Networks
Access to HIV specialists, infectious disease practitioners, sexual health clinicians, and hepatology experts across diverse care settings.
Comprehensive Condition Coverage
Evidence spanning HIV treatment and PrEP, hepatitis management, and HSV care.
Patient-Informed Intelligence
Evidence grounded in real patient experiences, including stigma, adherence, prevention acceptance, and psychosocial impacts.
Rigorous Methodology
Robust data collection capturing both clinical outcomes and patient-reported experiences.
Strategic Intelligence
Intelligence supporting clinical development, prevention strategies including PrEP optimization, reimbursement, and public health engagement.
Secondary Data Capabilities
- 115 secondary RWD studies since 2014, covering 50+ disease areas and 35+ data sources globally
- Studies across multiple evidence archetypes, including classification algorithms, comparative effectiveness, treatment patterns, HCRU, economic modelling, and safety
- 30+ RWD landscaping and feasibility projects since 2017, across 80+ geographies and 25+ disease areas, covering 2000+ real world data sources worldwide
- Patient, caregiver, physician surveys (BOI, preference, trade-offs, satisfaction, adherence etc)
- Retrospective chart reviews
- Qualitative studies
- Wearables & digital endpoints
- Longitudinal studies
Who We Collaborate With
We partner with biopharmaceutical innovators, HIV and sexual health centers, hepatology specialists, public health organizations, patient advocacy groups, and healthcare commissioners to advance chronic viral infection research and improve outcomes for patients globally.
Let’s Explore Together
-
Schedule a Consultation: Connect with our infectious disease specialists to discuss how our real-world evidence supports your chronic viral infection initiatives.
-
Discover More: Want to learn about our specialist networks, global footprint, condition expertise, or prevention-focused approach for HIV, hepatitis, and HSV? Contact us for detailed insights.
Let’s collaborate to generate evidence that drives innovation and better outcomes for chronic infections diseases.
Contact us today using the form below.
Respiratory Infection DSPs
Conferences Attending